Literature DB >> 31502877

Beyond Tethering the Viral Particles: Immunomodulatory Functions of Tetherin (BST-2).

Ritudhwaj Tiwari1, Juan C de la Torre2, Dorian B McGavern3, Debasis Nayak1.   

Abstract

Host response to viral infection is a highly regulated process involving engagement of various host factors, cytokines, chemokines, and stimulatory signals that pave the way for an antiviral immune response. The response is manifested in terms of viral sequestration, phagocytosis, and inhibition of genome replication, and, finally, if required, lymphocyte-mediated clearance of virally infected cells. During this process, cross-talk between viral and host factors can shape disease outcomes and immunopathology. Bone marrow stromal antigen 2 (BST-2), also know as tetherin, is induced by type I interferon produced in response to viral infections, as well as in certain cancers. BST-2 has been shown to be a host restriction factor of virus multiplication through its ability to physically tether budding virions and restrict viral spread. However, BST-2 has other roles in the host antiviral response. This review focuses on the diverse functions of BST-2 and its downstream signaling pathways in regulating host immune responses.

Entities:  

Keywords:  antiviral; cancer; immunomodulatory; tetherin

Mesh:

Substances:

Year:  2019        PMID: 31502877      PMCID: PMC6939588          DOI: 10.1089/dna.2019.4777

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  73 in total

Review 1.  IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors.

Authors:  Kenya Honda; Tadatsugu Taniguchi
Journal:  Nat Rev Immunol       Date:  2006-09       Impact factor: 53.106

2.  SAGE library screening reveals ILT7 as a specific plasmacytoid dendritic cell marker that regulates type I IFN production.

Authors:  Minkwon Cho; Koji Ishida; Jingtao Chen; Jun Ohkawa; Wei Chen; Sahori Namiki; Ayumi Kotaki; Naoko Arai; Ken-ichi Arai; Yumiko Kamogawa-Schifter
Journal:  Int Immunol       Date:  2007-11-28       Impact factor: 4.823

3.  Osteoblast-enriched membrane protein IFITM5 regulates the association of CD9 with an FKBP11-CD81-FPRP complex and stimulates expression of interferon-induced genes.

Authors:  Nobutaka Hanagata; Xianglan Li
Journal:  Biochem Biophys Res Commun       Date:  2011-05-11       Impact factor: 3.575

4.  Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane.

Authors:  Jason Hammonds; Jaang-Jiun Wang; Hong Yi; Paul Spearman
Journal:  PLoS Pathog       Date:  2010-02-05       Impact factor: 6.823

5.  Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction.

Authors:  Wei Cao; Laura Bover; Minkwon Cho; Xiaoxia Wen; Shino Hanabuchi; Musheng Bao; David B Rosen; Yi-Hong Wang; Joanne L Shaw; Qiumei Du; Chun Li; Naoko Arai; Zhengbin Yao; Lewis L Lanier; Yong-Jun Liu
Journal:  J Exp Med       Date:  2009-06-29       Impact factor: 14.307

6.  HM1.24 (CD317) is a novel target against lung cancer for immunotherapy using anti-HM1.24 antibody.

Authors:  Wei Wang; Yasuhiko Nishioka; Shuji Ozaki; Ali Jalili; Shinji Abe; Soji Kakiuchi; Masatoshi Kishuku; Kazuo Minakuchi; Toshio Matsumoto; Saburo Sone
Journal:  Cancer Immunol Immunother       Date:  2008-11-01       Impact factor: 6.968

7.  Regulation of Toll-like receptor signaling by NDP52-mediated selective autophagy is normally inactivated by A20.

Authors:  Megumi Inomata; Shumpei Niida; Ken-ichiro Shibata; Takeshi Into
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

8.  Structural determinant of BST-2-mediated regulation of breast cancer cell motility: a role for cytoplasmic tail tyrosine residues.

Authors:  Wasifa Naushad; Wadie D Mahauad-Fernandez; Chioma M Okeoma
Journal:  Oncotarget       Date:  2017-11-29

9.  Cysteine-linked dimerization of BST-2 confers anoikis resistance to breast cancer cells by negating proapoptotic activities to promote tumor cell survival and growth.

Authors:  Wadie D Mahauad-Fernandez; Chioma M Okeoma
Journal:  Cell Death Dis       Date:  2017-03-16       Impact factor: 8.469

10.  Tetherin inhibits HIV-1 release by directly tethering virions to cells.

Authors:  David Perez-Caballero; Trinity Zang; Alaleh Ebrahimi; Matthew W McNatt; Devon A Gregory; Marc C Johnson; Paul D Bieniasz
Journal:  Cell       Date:  2009-10-30       Impact factor: 41.582

View more
  6 in total

Review 1.  The Virus-Host Interplay in Junín Mammarenavirus Infection.

Authors:  Giovanna Lucrecia Gallo; Nora López; María Eugenia Loureiro
Journal:  Viruses       Date:  2022-05-24       Impact factor: 5.818

2.  Bone marrow stromal cell antigen 2(BST2) suppresses the migration and invasion of trophoblasts in preeclampsia by downregulating matrix metallopeptidase 2(MMP2).

Authors:  Liu Jinyu; Wang Shuying; Zheng Panchan; Chen Dan; Chen Chao; Yang Xingyu; Cheng Weiwei
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Uncovering transcriptional dark matter via gene annotation independent single-cell RNA sequencing analysis.

Authors:  Michael F Z Wang; Madhav Mantri; Shao-Pei Chou; Gaetano J Scuderi; David W McKellar; Jonathan T Butcher; Charles G Danko; Iwijn De Vlaminck
Journal:  Nat Commun       Date:  2021-04-12       Impact factor: 14.919

4.  Tumour-associated CD204+ microglia/macrophages accumulate in perivascular and perinecrotic niches and correlate with an interleukin-6-enriched inflammatory profile in glioblastoma.

Authors:  Mia D Sørensen; Bjarne W Kristensen
Journal:  Neuropathol Appl Neurobiol       Date:  2022-01-05       Impact factor: 6.250

Review 5.  The RING finger protein family in health and disease.

Authors:  Chunmei Cai; Yan-Dong Tang; Jingbo Zhai; Chunfu Zheng
Journal:  Signal Transduct Target Ther       Date:  2022-08-30

Review 6.  Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy.

Authors:  Sabina Sánchez Hernández; Martin Roelsgaard Jakobsen; Rasmus O Bak
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.